Dr. Neil Spector, from Duke Cancer Institute, Explains Breast Cancer Heterogeneity
Neil L. Spector, MD
Advertisement
Articles by Neil L. Spector, MD
Dr. Neil Spector, from Duke Cancer Institute, Emphasizes the Importance of Studying Tumor Microenvironments
Dr. Neil Spector, from Duke Cancer Institute, Discusses the Systemic Nature of Cancer
Dr. Neil Spector, from the Duke Cancer Institute, Discusses the Complexities of Cancer
Advertisement
Latest Updated Articles
Dr. Spector Discusses the Complexities of CancerPublished: March 26th 2012 | Updated:
Dr. Spector on the Importance of Tumor MicroenvironmentsPublished: April 30th 2012 | Updated:
Dr. Spector Discusses the Systemic Nature of CancerPublished: April 10th 2012 | Updated:
Dr. Spector Discusses Breast Cancer HeterogeneityPublished: May 14th 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5